Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database

A better understanding of immune-related adverse events is essential for the early detection and appropriate management of these phenomena. We conducted an observational study of cases recorded at the French reference center for hypereosinophilic syndromes and in the French national pharmacovigilanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Scanvion, Quentin, Béné, Johana, Gautier, Sophie, Grandvuillemin, Aurélie, Le Beller, Christine, Chenaf, Chouki, Etienne, Nicolas, Brousseau, Solenn, Cortot, Alexis B., Mortier, Laurent, Staumont-Sallé, Delphine, Morschhauser, Franck, Forestier, Alexandra, Groh, Matthieu, Launay, David, Hachulla, Eric, Labalette, Myriam, Kahn, Jean-Emmanuel, Lefèvre, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153834/
https://www.ncbi.nlm.nih.gov/pubmed/32313716
http://dx.doi.org/10.1080/2162402X.2020.1722022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153834/
https://www.ncbi.nlm.nih.gov/pubmed/32313716
http://dx.doi.org/10.1080/2162402X.2020.1722022

Ejemplares similares